Professional Summary

Professional Overview

Gene Merutka is a seasoned pharmaceutical executive with over 25 years of experience in the industry. He currently serves as the Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Operations at Sapience Therapeutics, Inc., where he oversees the critical aspects of product development and manufacturing.

Experience Summary

Current Role

As the SVP of CMC and Operations at Sapience Therapeutics, Gene is responsible for leading the company's CMC and operations functions. He is instrumental in ensuring the successful development and manufacturing of the organization's drug candidates, contributing to the advancement of their pipeline and bringing innovative therapies to patients.

Career Progression

Throughout his distinguished career, Gene has held several leadership positions within the pharmaceutical industry. He co-founded Merganser Biotech, Inc. and served as the Senior Vice President of Development, where he played a pivotal role in the company's growth and success. Prior to that, he held the role of Vice President and Head of CMC and CMC Regulatory Affairs at Azelon Pharmaceuticals, as well as senior positions at Vicuron Pharmaceuticals, IntraBiotics Pharmaceuticals, and Trimeris.

Academic Background

Gene holds a Ph.D. in Pharmaceutical Chemistry from The Scripps Research Institute, where he conducted extensive postdoctoral research.

Areas of Expertise

Gene's areas of expertise include:

• Chemistry, Manufacturing, and Controls (CMC)

• Pharmaceutical product development

• Regulatory affairs and compliance

• Operations management

• Strategic planning and execution

• Team leadership and collaboration

Professional Impact

Throughout his career, Gene has made significant contributions to the pharmaceutical industry. He has successfully navigated complex regulatory environments, overseen the development and manufacturing of numerous drug candidates, and fostered collaborative partnerships to drive innovation. His expertise and leadership have been instrumental in advancing the progress of the companies he has been associated with.

Conclusion

With his deep industry knowledge, technical expertise, and proven track record of success, Gene Merutka continues to make a lasting impact in the pharmaceutical field. As the SVP of CMC and Operations at Sapience Therapeutics, he is well-positioned to guide the company's growth and contribute to the development of transformative therapies that improve patient outcomes.